Zantac Could Be Responsible For The Obesity Epidemic

Being overweight leads to heartburn resulting in esophageal cancer, a life-threatening disease

Sunday, March 28, 2021 - Zantac was a medicine that helped millions of people find relief from heartburn and acid indigestion pain. At the time Sanofi, the maker of the prescription and over-the-counter drug, voluntarily recalled it, more than 15 million Americans reached for a Zantac every day. Despite being so popular, Zantac may have hurt more people than it helped. Even beyon containing NDMA, the carcinogen found in Zantac tablets that prompted the FDA to banish ranitidine and thousands of Zantac cancer lawsuits. Zantac's pain-relieving properties may have masked an underlying medical problem, which may have enabled millions of Americans to think that it was ok to overeat unhealthy foods.

Overeating is the primary reason that heartburn occurs. Filling the stomach more than it can comfortably hold forces the esophageal sphincter to remain open and to allow stomach contents to spill up into the esophagus taking stomach acid with it. The esophagus does not have the protective lining that the stomach has, and the pain of heartburn is a chemical burn on the esophagus. A chemical burn caused by stomach acid can, over time, result in esophageal cancer. Eventually, the heartburn chest pain one suffers could be the pain from esophageal cancer and not because of overeating. Overeaters have a real health crisis on their hands when their antacid medicine no longer provides pain relief.

The NationalLawReview writes, "Many of us suffer heartburn at one time or another, whether due to stress or overeating, but persistent heartburn could be a symptom of a more serious problem. If you consistently experience acid reflux that lasts for a couple of weeks and changing your diet does not seem to make a difference, it's time to see a doctor. Persistent heartburn could be a symptom of stomach, throat, or ovarian cancer." Warning symptoms of esophageal cancer are relying on antacids regularly for many years, difficulty swallowing, and subsequently weight loss. Other signs are a persistent cough or hoarseness in the voice, and chest pain. Cancer.net writes that age and sex have bearing on those who are likely to get esophageal cancer. "People between the ages of 45 and 70 have the highest risk of esophageal cancer. Gender. Men are 3 to 4 times more likely than women to develop esophageal cancer." This demographic, not coincidently, is the same as the one most likely to use Zantac and other antacid medicines. Left untreated, esophageal cancer may spread to the lungs, lymph nodes, and liver. LifeSpan.org recognized that the symptoms of esophageal cancer can be the same as the symptoms of heartburn. "Someone with esophageal cancer may experience pain in the middle of the chest that feels like pressure or burning. This discomfort can often be confused with other problems, such as heartburn, so it is difficult to recognize it as a symptom."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.